UC-II® Stars in Jamiesons Collagen Glucosamine Complex

BENICIA, Calif.UC-II®, a joint-health ingredient from InterHealth, is featured in the new once-a-day UC-II®/glucoasamine joint-health product from Jamieson Laboratories. The supplement was introduced in mid-March for distribution across the Canadian food, drug, mass merchandisers channel.

Jamiesons Collagen Glucosamine Complex delivers 40 mg of UC-II® undenatured type II collagen made and sourced in North America from chicken cartilage. According to InterHealth, peer-reviewed published clinical research conducted in North America showed 40 mg of UC-II® a day increases joint mobility, flexibility and quality of life twice as effectively as glucosamine-chondroitin.

We are very excited to have UC-II® represented by Jamiesona pioneer in the natural healthcare market," stated Paul Dijkstra, InterHealths CEO. Given the brand recognition and consumer trust in Jamieson and UC-II®s proven benefits, Collagen Glucosamine Complex is certain to attract consumer attention, helping to make a difference in peoples lives." Dijkstra added that InterHealth offers support to all their partners. We have a vested interest in the success of the finished products that use our ingredients. We worked closely with Jamieson to help provide consumers with an enhanced joint-health product offering. Additionally, our R&D and marketing staff traveled to Canada to help train Jamiesons sales force on UC-II®s product benefits and clinical research, helping to ensure success of Collagen Glucosamine Complex."

Jillian Mariani, director of brand marketing at Jamieson Laboratories, noted, We love that the efficacious dose of UC-II® is only 40 mg a day; this makes the product that much more marketable to consumers not only dealing with joint discomfort and pain, but suffering from pill fatigue as well. It provides a once daily option within our line of, and Canadas best-selling, glucosamine-based joint care products. UC-II®s published peer-reviewed clinical research demonstrating twice the efficacy as glucosamine-chondroitin as well as its unique mechanism provides us with relevant and consumer-friendly product health claims. Consumers know that glucosamine-chondroitin products have efficacy, so having a study that shows that UC-II® may be much more effective provides another viable choice to consumers that are suffering, or who have not had success with glucosamine-chondroitin alone." Mariani added, The solid efficacy and safety research on UC-II® meets with Jamieson 360Pure quality protocols, an industry-leading process that exceeds the requirements of Health Canada."